Femasys Inc (FEMY)

Name: Femasys Inc (FEMY) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Femasys Inc (FEMY)

Stock Card

$2.98

$-0.08 (-2.61%)

As on 04-Sep-2026 16:00EDT

Market cap

$25 Mln

Revenue (TTM)

$2 Mln

P/E Ratio

P/B Ratio

6.5

Div. Yield

0 %

Femasys Inc (FEMY) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 2.93 High: 3.06

52 Week Range

Low: 2.02 High: 139.96

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-4.2 %
ROCE

-- %
Industry P/E

46.09
EV/EBITDA

0.2
Debt to Equity

0.9
Book Value

$1.3
EPS

$-6.1
Face value

--
Shares outstanding

8,375,027

5 Years Aggregate

CFO

$-45.88 Mln

EBITDA

$-47.30 Mln

Net Profit

$-51.37 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Femasys Inc (FEMY)	-74.1	0.3	-59.5	-59.7	-30.8	-54.1	--
BSE Sensex	-9.6	-2.7	2.9	-5.0	5.4	5.7	10.4
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 04-Sep-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022
Femasys Inc (FEMY)	-47.6	12.7	8.3	-76.9
S&P Small-Cap 600	4.0	7.0	13.9	-17.4
BSE Sensex	9.1	8.1	18.7	4.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Femasys Inc (FEMY)	3.0	25.0	2.3	-12.3	-454.8	-248.2	--	6.5
10X Genomics Inc (TXG)	62.7	8,162.7	616.9	-75.1	1.7	-9.3	--	10.0
Avantor (AVTR)	15.0	10,125.1	6,561.1	-578.0	-4.5	-10.3	--	1.8
Bio-Rad Laboratories	365.1	9,761.6	2,589.3	222.4	-6.0	3	44.5	1.4
Bruker (BRKR)	58.5	8,913.0	3,499.6	-71.2	0.5	-3.2	--	3.8
Glaukos Corp (GKOS)	177.5	10,637.8	612.8	-188.1	-30.6	-28.1	--	15.3
Lantheus Holdings (LNTH)	101.0	6,590.6	1,556.3	275.3	24.6	22.9	24.2	5.0
Penumbra (PEN)	322.2	12,649.5	1,504.9	160.6	13.6	10.9	79.3	8.3
Repligen (RGEN)	167.6	9,458.6	785.1	41.5	9.9	2	232.8	4.6
Smith & Nephew SNATS - ADR	28.9	12,007.0	6,164.0	625.0	13.0	11.8	19.5	2.3

Shareholding Pattern

View Details

About Femasys Inc (FEMY)

Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device;... FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia. Read more

Founder, President, CEO & Director

Ms. Kathy Lee-Sepsick M.B.A.
Founder, President, CEO & Director

Ms. Kathy Lee-Sepsick M.B.A.
Headquarters

Suwanee, GA
Website

https://femasys.com

FAQs for Femasys Inc (FEMY)

What is the current share price of Femasys Inc (FEMY) Today?

The share price of Femasys Inc (FEMY) is $2.98 (NASDAQ) as of 04-Sep-2026 16:00 EDT. Femasys Inc (FEMY) has given a return of -30.82% in the last 3 years.

What is the current PB & PE ratio of Femasys Inc (FEMY)?

Since, TTM earnings of Femasys Inc (FEMY) is negative, P/E ratio is not available.
The P/B ratio of Femasys Inc (FEMY) is 6.46 times as on 04-Sep-2026, a 71 premium to its peers’ median range of 3.78 times.

PE & PB ratio at the end of financial year.